These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37504249)

  • 61. Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: a possible diagnostic tool for the diagnosis of leiomyosarcoma.
    Poncelet C; Walker F; Madelenat P; Bringuier AF; Scoazec JY; Feldmann G; Darai E
    Hum Pathol; 2001 Nov; 32(11):1190-6. PubMed ID: 11727257
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression analysis of CD44 isoforms S and V3, in patients with esophageal squamous cell carcinoma.
    Mansouri A; Foroughmand AM; Abbaszadegan MR; Memar B; Mahmoudian RA; Gholamin M
    Iran J Basic Med Sci; 2015 Apr; 18(4):380-4. PubMed ID: 26019801
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa.
    Gorham H; Sugino T; Woodman AC; Tarin D
    J Clin Pathol; 1996 Jun; 49(6):482-8. PubMed ID: 8763263
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.
    Kuniyasu H; Oue N; Tsutsumi M; Tahara E; Yasui W
    Clin Cancer Res; 2001 Dec; 7(12):4067-72. PubMed ID: 11751503
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
    Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
    Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
    Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
    Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
    Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns.
    Miyake H; Hara I; Kamidono S; Eto H
    J Urol; 2004 Sep; 172(3):1127-9. PubMed ID: 15311055
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse.
    Beham-Schmid C; Heider KH; Hoefler G; Zatloukal K
    J Pathol; 1998 Dec; 186(4):383-9. PubMed ID: 10209487
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma.
    Kanke M; Fujii M; Kameyama K; Kanzaki J; Tokumaru Y; Imanishi Y; Tomita T; Matsumura Y
    Arch Otolaryngol Head Neck Surg; 2000 Oct; 126(10):1217-23. PubMed ID: 11031408
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
    Bourguignon LY; Gunja-Smith Z; Iida N; Zhu HB; Young LJ; Muller WJ; Cardiff RD
    J Cell Physiol; 1998 Jul; 176(1):206-15. PubMed ID: 9618160
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Insights into the structural perturbations of spliced variants of CD44: a modeling and simulation approach.
    Patel S; Shaikh F; Devaraji V; Radadiya A; Shah K; Shah A; Rawal R
    J Biomol Struct Dyn; 2017 Feb; 35(2):354-367. PubMed ID: 26766750
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications.
    Li G; Suzuki H; Asano T; Tanaka T; Suzuki H; Kaneko MK; Kato Y
    Antibodies (Basel); 2022 Jun; 11(2):. PubMed ID: 35735360
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers.
    Nanamiya R; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2023 Oct; 42(5):166-177. PubMed ID: 37824755
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component.
    Umeda T; Ishida M; Murata S; Mori T; Kawai Y; Itoi N; Tomida K; Tanaka A; Sakai S; Kitamura M; Kubota Y; Kushima R; Tani M
    Breast Cancer; 2016 Nov; 23(6):869-875. PubMed ID: 26494575
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen).
    Alves CS; Yakovlev S; Medved L; Konstantopoulos K
    J Biol Chem; 2009 Jan; 284(2):1177-89. PubMed ID: 19004834
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New CD44 splice variants associated with human breast cancers.
    Iida N; Bourguignon LY
    J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CD44 expression in astrocytic tumors.
    Ylagan LR; Quinn B
    Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.